We are more than a tech transfer office. We are a medical innovations powerhouse. Cleveland Clinic Innovations brings the best ideas from the brightest minds in medicine to patients around the world. We connect inventors and their ideas with strategic industry partners to create products that transform the future of healthcare. Cleveland Clinic is changing healthcare for patients around the world. https://39682636.hs-sites.com/bio-home | x | Cleveland Clinic Innovations (CCI) is dedicated to turning caregiver-inspired ideas into medical breakthroughs that meaningfully improve patient lives. Since 2000, our team has transformed over 900 technologies into licensed products, secured more than 2,800 patents, and launched over 100 spin-off companies, achieving 28 successful exits. Our multidisciplinary team works side-by-side with clinicians, researchers, and industry to guide innovations through every stage, from concept to licensing, startup formation, clinical validation, and scaling. We’re more than a technology transfer office, we’re strategic partners in transforming healthcare innovation. Whether it’s harnessing AI for diagnostics, pioneering digital health solutions, developing novel therapeutics, or creating advanced drug delivery systems, we ensure that innovative ideas become practical solutions impacting patient care globally. Technologies available for licensing include: · Digital Health · Drug Delivery · Diagnostics · Therapeutics · Research Tools What Makes Cleveland Clinic Innovations Unique? · Direct clinician and researcher access for rapid, real-world healthcare insights. · Robust clinical validation and real-world data-driven innovation within a globally recognized health system. · Comprehensive IP management, strategic licensing expertise, and proven healthcare startup incubation. Why partner with Cleveland Clinic Innovations? · Expert guidance through healthcare startup creation, technology transfer, and commercialization pathways. · Integrated access to world-class clinical, regulatory, and research infrastructure. · Global presence supporting innovations across markets (U.S., London, Abu Dhabi, Canada). Together, we can accelerate healthcare innovation and create meaningful patient impact. Explore our technologies and partner with us: https://my.clevelandclinic.org/innovations
Clementine
World’s first AI Audiologist: 1.5 billion people have hearing loss, yet 80% don’t seek support due to stigma and low awareness. As hearing loss is the No1 preventable cause of dementia, Clementine AI’s self-test and education platform breaks these barriers, driving swift action and redefining hearing health as vital to lifelong wellness.
ClearSurgery
ClearSurgery delivers the physicians’ personal digital sphere, an immersive environment for that centralizes video streams and patient data, enhancing performance and safety in sterile environments while reducing operating room costs.
Clarivate
At Clarivate, we empower our Life Sciences & Healthcare customers to deliver treatments that improve patient lives and create a healthier tomorrow. Our market leading intelligence solutions and transformative data technology equip our customers with the insight and foresight needed across all their initiatives from early-stage drug discovery right through commercialization and beyond. As a global leader, Clarivate has one of the most comprehensive life science intelligence portfolios on the market. What sets us above the rest is the quality of our insight, our deep industry expertise and our connective data technology capabilities that allow us to transform intelligence into the answers our customers need to solve healthcare’s biggest challenges. Ultimately, our solutions help our customers create innovative treatments, deliver them to patients faster and improve quality of life. | Clarivate™ is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. Our connected data, deep expertise and intelligence platforms empower life sciences and healthcare companies to deliver safe, effective and commercially successful treatments to patients faster. Clarivate is home to Cortellis™, solutions for real world data, medtech, market access and commercialization and deep consulting expertise. | Clarivate™ is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. Our connected data, deep expertise and intelligence platforms empower life sciences and healthcare companies to deliver safe, effective and commercially successful treatments to patients faster. Clarivate is home to Cortellis™, solutions for real world data, medtech, market access and commercialization and deep consulting expertise. In today’s rapidly evolving world, staying innovative is crucial to engaging patients, physicians, and payers in new and effective ways. At Clarivate, we have long embraced advanced analytics and AI in our products, enabling us to help you reimagine workflows, gain insights faster and anticipate the challenges or successes ahead. Our unified data sets allow you to access and analyze a wide range of data, from epidemiologic and scientific information to clinical and commercial data, all within a single platform. This empowers you to make evidence-based decisions and conduct complex analyses that drive your business forward.
City of Hope
City of Hope’s mission is to make hope a reality for all touched by cancer and diabetes. Founded in 1913, City of Hope has grown into one of the largest and most advanced cancer research and treatment organizations in the U.S., and one of the leading research centers for diabetes and other life-threatening illnesses. City of Hope research has been the basis for numerous breakthrough cancer medicines, as well as human synthetic insulin and monoclonal antibodies. With an independent, National Cancer Institute-designated comprehensive cancer center that is ranked top 5 in the nation for cancer care by U.S. News & World Report at its core, City of Hope’s uniquely integrated model spans cancer care, research and development, academics and training, and a broad philanthropy program that powers its work. City of Hope’s growing national system includes its Los Angeles campus, a network of clinical care locations across Southern California, a new cancer center in Orange County, California, and cancer treatment centers and outpatient facilities in the Atlanta, Chicago and Phoenix areas. City of Hope’s affiliated group of organizations includes Translational Genomics Research Institute and AccessHopeTM. For more information about City of Hope, follow us on Facebook, X, YouTube, Instagram and LinkedIn. | City of Hope’s mission is to deliver the cures of tomorrow to the people who need them today. Founded in 1913, City of Hope has grown into one of the largest cancer research and treatment organizations in the U.S. and one of the leading research centers for diabetes and other life-threatening illnesses. City of Hope research has been the basis for numerous breakthrough cancer medicines, as well as human synthetic insulin and monoclonal antibodies. With an independent, National Cancer Institute-designated comprehensive cancer center at its core, City of Hope brings a uniquely integrated model to patients spanning cancer care, research and development, academics and training, and innovation initiatives. City of Hope’s growing national system includes its Los Angeles campus, a network of clinical care locations across Southern California, a new cancer center in Orange County, California, and treatment facilities in Atlanta, Chicago and Phoenix. City of Hope’s affiliated group of organizations includes Translational Genomics Research Institute and AccessHopeTM. For more information about City of Hope, follow us on Facebook, Twitter, YouTube, Instagram and LinkedIn. | City of Hope’s mission is to make hope a reality for all touched by cancer and diabetes. Founded in 1913, City of Hope has grown into one of the largest cancer research and treatment organizations in the U.S. and one of the leading research centers for diabetes and other life-threatening illnesses. City of Hope research has been the basis for numerous breakthrough cancer medicines, as well as human synthetic insulin and monoclonal antibodies. With an independent, National Cancer Institute-designated comprehensive cancer center at its core, City of Hope brings a uniquely integrated model to patients spanning cancer care, research and development, academics and training, and innovation initiatives. City of Hope’s growing national system includes its Los Angeles campus, a network of clinical care locations across Southern California, a new cancer center in Orange County, California, and cancer treatment centers and outpatient facilities in the Atlanta, Chicago and Phoenix areas. City of Hope’s affiliated group of organizations includes Translational Genomics Research Institute and AccessHopeTM. For more information about City of Hope, follow us on Facebook, X, YouTube, Instagram and LinkedIn. | City of Hope is a world leader in cancer research, treatment and care. Since 1913, we have been dedicated to making a meaningful impact in the fight against life-threatening illnesses. Accordint o U.S. News and World Report, City of Hope is a top 5 cancer center in the United States and #1 in California. City of Hope’s Charitable Remainder Trust (CRT) program enables agricultural property owners to bypass capital gains tax when selling appreciated property. Additional benefits include creating a new source of lifetime income for the property owner and/or loved ones, a charitable income tax deduction and is a viable succession plan option for those who would like to downsize or retire from the property ownership business. In accordance with the IRS Code, a Charitable Remainder Trust (CRT) is a separate legal and charitable entity. When transferring property into a CRT first, the trust can sell the donated property and bypass capital gains tax at the time of the sale. After the donor’s lifetime, City of Hope will have access to the remaining funds for use towards research, making a difference in the lives of people with cancer, diabetes and other life-threatening illnesses.
CitiusTech
CitiusTech is a global technology services, consulting, and business solutions enterprise 100% focused on the healthcare and life sciences industry. We enable 140+ enterprises to build a human-first ecosystem that is efficient, effective, and equitable. Leveraging deep domain expertise and next-generation technologies including AI, Cloud, Data, and Intelligent Automation, we assist our clients in realizing their vision, accelerate transformation, and achieve business outcomes. With 7,700+ healthcare technology professionals worldwide, CitiusTech powers digital innovation, business transformation, and industry-wide convergence through next-generation technologies, solutions, and products. Follow CitiusTech on Twitter or LinkedIn.
Cincinnati Children’s Hospital
Cincinnati Children’s Hospital is dedicated to being a leader in improving child health. We offer family-centered care, groundbreaking research, and renowned teaching programs. As a national and international referral center for complex cases, we have pioneered clinical procedures and treatments that are used worldwide. Cincinnati Children’s is consistently ranked among the top three children’s hospitals in the United States by US News and World Report. Explore our conference microsite by clicking the “Website” button below to discover how we can collaborate and make a difference together.
Cincinnati Children’s Innovation Ventures
Cincinnati Children’s is a nationally ranked pediatric health system and a recognized leader in both pediatric and adult research. With a legacy of impact spanning more than 90 years—from Albert Sabin’s oral polio vaccine to pioneering discoveries in lung surfactant proteins—we continue to advance science that improves lives. As one of the largest pediatric research institutions in the U.S., we secure $300 million in external research funding annually and play a central role in shaping the future of biomedical innovation. Innovation is embedded in our culture. One-third of our 19,000 employees are engaged in research and innovation across a broad spectrum of life sciences. From breakthrough therapeutic candidates and biotech platforms to diagnostics, medical devices, software, and research tools, our teams are building a pipeline of technologies with the potential for real-world impact. Explore our innovation portfolio and partnership opportunities at cincinnatichildrens.org/innovation-ventures.